UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 320

Sortiert nach

Isolated distal deep vein thrombosis: what we know and what we are doing

Journal of thrombosis and haemostasis, 2012-01, Vol.10 (1), p.11-19

2012

Link zum Volltext

Verfügbarkeit prüfen

Isolated distal deep vein thrombosis: what we know and what we are doing

Journal of thrombosis and haemostasis, 2012-01, Vol.10 (1), p.11-19

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2313-2315

2010

Link zum Volltext

Verfügbarkeit prüfen

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

Journal of thrombosis and haemostasis, 2018-05, Vol.16 (5), p.842-848

2018

Link zum Volltext

Verfügbarkeit prüfen

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2436-2442

2010

Link zum Volltext

Verfügbarkeit prüfen

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1019-1025

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

International journal of laboratory hematology, 2016-02, Vol.38 (1), p.42-49

2016

Link zum Volltext

Verfügbarkeit prüfen

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.1994-2002

2018

Link zum Volltext

Verfügbarkeit prüfen

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2194-2201

2016

Link zum Volltext

Verfügbarkeit prüfen

New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation

Journal of internal medicine, 2012-06, Vol.271 (6), p.554-565

2012

Link zum Volltext

Verfügbarkeit prüfen

External validation of the DASH prediction rule: a retrospective cohort study

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1963-1970

2017

Link zum Volltext

Verfügbarkeit prüfen

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

Europace (London, England), 2011-05, Vol.13 (5), p.723-746

2011

Link zum Volltext

Verfügbarkeit prüfen

The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study: comment

Journal of thrombosis and haemostasis, 2015-12, Vol.13 (12), p.2283-2286

2015

Link zum Volltext

Verfügbarkeit prüfen

Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment

European journal of vascular and endovascular surgery, 2016-11, Vol.52 (5), p.658-664

2016

Link zum Volltext

Verfügbarkeit prüfen

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism

Journal of thrombosis and haemostasis, 2008-08, Vol.6 (8), p.1327-1333

2008

Link zum Volltext

Verfügbarkeit prüfen

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

Journal of thrombosis and haemostasis, 2018-12, Vol.16 (12), p.2539-2540

2018

Link zum Volltext

Verfügbarkeit prüfen

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.775-781

2015

Link zum Volltext

Verfügbarkeit prüfen

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

International journal of cardiology, 2021-03, Vol.327, p.176-182

2021

Link zum Volltext

Verfügbarkeit prüfen

The Wells rule and D‐dimer for the diagnosis of isolated distal deep vein thrombosis

Journal of thrombosis and haemostasis, 2012-11, Vol.10 (11), p.2264-2269

2012

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1297-1302

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum)

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1026-1035

2012

Link zum Volltext

Verfügbarkeit prüfen

Bleeding with anticoagulant treatments

Hämostaseologie, 2011-11, Vol.31 (4), p.237

Palareti, G

2011

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation for venous thromboembolism: what if they bleed?

Hämostaseologie, 2012, Vol.32 (1), p.40

Palareti, G

2012

Link zum Volltext

Verfügbarkeit prüfen

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long‐term recurrence

Journal of thrombosis and haemostasis, 2005-05, Vol.3 (5), p.955-961

2005

Link zum Volltext

Verfügbarkeit prüfen

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

Journal of thrombosis and haemostasis, 2005-03, Vol.3 (3), p.459-464

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(213)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(229)
Science & Technology
(191)
Life Sciences & Biomedicine
(190)
Female
(135)
Male
(130)
Hematology
(126)
Middle Aged
(126)
Adult
(107)
Aged
(100)
Cardiovascular System & Cardiology
(96)
Biological And Medical Sciences
(94)
Medical Sciences
(93)
Peripheral Vascular Disease
(89)
Risk Factors
(57)
Adolescent
(51)
Aged, 80 And Over
(48)
Anticoagulants - Administration & Dosage
(41)
Anticoagulants - Therapeutic Use
(41)
Administration, Oral
(39)
Recurrence
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thrombosis And Haemostasis
(48)
Thrombosis And Haemostasis
(30)
Thrombosis Research
(27)
Fibrinolysis
(13)
Haematologica
(13)
Minerva Cardioangiologica
(10)
British Journal Of Haematology
(9)
Haemostasis
(8)
The Lancet
(8)
Blood Coagulation & Fibrinolysis
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Isolated distal deep vein thrombosis: what we know and what we are doing

Isolated distal deep vein thrombosis: what we know and what we are doing

Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation

External validation of the DASH prediction rule: a retrospective cohort study

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study: comment

Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

The Wells rule and D‐dimer for the diagnosis of isolated distal deep vein thrombosis

Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum)

Bleeding with anticoagulant treatments

Anticoagulation for venous thromboembolism: what if they bleed?

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long‐term recurrence

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

Suchergebnisse filtern